Director
Director at ADARx Pharmaceuticals, Inc., filing insider transactions between 2026-06-30 and 2026-09-28. Also reports transactions at 5 other companies.
ADARx Pharmaceuticals, Inc.
Electra Therapeutics, Inc.
BlossomHill Therapeutics, Inc.
Braveheart Bio, Inc.
Scribe Therapeutics, Inc.
Sionna Therapeutics, Inc.
| SEC ↗ |
| 2026-09-21 | ETRA | Purchase | 333.3K | $15.00 | $5.0M | SEC ↗ |
| 2026-09-21 | ETRA | Purchase | 1.00M | $15.00 | $15.0M | SEC ↗ |
| 2026-08-10 | BLSM | Purchase | 625.0K | $16.00 | $10.0M | SEC ↗ |
| 2026-08-07 | BRVE | Purchase | 1.67M | $18.00 | $30.0M | SEC ↗ |
| 2026-08-07 | BRVE | Purchase | 273.3K | $18.00 | $4.9M | SEC ↗ |
| 2026-07-27 | SCTX | Purchase | 1.00M | $15.00 | $15.0M | SEC ↗ |
| 2026-07-07 | SION | Sale | 85.9K | $44.86 | $3.9M | SEC ↗ |
| 2026-06-30 | SION | Sale | 115.8K | $45.50 | $5.3M | SEC ↗ |